Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
주식 순위 #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
주가
$0.00023723
마지막 동기화: 2024-08-26
시가총액
$1.41K
변동 (1일)
111.67%
변동 (1년)
0.00%
국가
FR
거래 Pharnext S.A. (ALPHA)

카테고리

Pharnext S.A. (ALPHA)의 주식 분할 이력
Pharnext S.A. 주식 (심볼: ALPHA)은 총 4회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Feb 15, 2024에 발생했습니다.
Nov 23, 2022 이전에 매수한 ALPHA 주식 1주는 현재 4.0E-16주의 ALPHA 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2024-02-15 1:10000 x0.0001 x4.0E-16
2023-09-18 1:5000 x0.0002 x4.0E-12
2023-05-10 1:10000 x0.0001 x2.0E-8
2022-11-23 1:5000 x0.0002 x0.0002
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR